Chronic urticaria occurs in about 0.1% of the population (Greaves, 2000). Patients previously classified as having chronic idiopathic or "ordinary" urticaria are now divided into two groups ...
We still have a lot to learn about chronic idiopathic urticaria, a common and heterogeneous disorder. Most of these quiz questions are derived from recent literature and guideline updates.
Treating CIU with levocetirizine is dominant over placebo, i.e. it increases the number of pruritus-free days and leads to cost savings for society.
clinicaltrialsarena on MSN2d
Kashiv Biosciences’ Phase I trial of KSHB002 injection meets primary endpointsKashiv Biosciences has reported that a trial of its 125mg/mL pre-filled syringe injection, KSHB002, has achieved its primary ...
The allergy and immunology community mourns the loss of Marcus Maurer, MD, executive director of the Institute of Allergology ...
Dupixent is already approved to treat a range of inflammatory diseases including atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis, making $6 billion in global sales last ...
Detailed price information for Jasper Therapeutics Inc. (JSPR-Q) from The Globe and Mail including charting and trades.
These quiz questions about chronic idiopathic urticaria (CIU) are derived from current literature. Are you up to date? At the end of the quiz, compare your score with those of your physician ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback